GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CHA Vaccine Research Institute Co Ltd (XKRX:261780) » Definitions » Operating Cash Flow per Share

CHA Vaccine Research Institute Co (XKRX:261780) Operating Cash Flow per Share : ₩-198.44 (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is CHA Vaccine Research Institute Co Operating Cash Flow per Share?

CHA Vaccine Research Institute Co's operating cash flow per share for the three months ended in Dec. 2023 was ₩-18.07. CHA Vaccine Research Institute Co's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-198.44.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 3.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for CHA Vaccine Research Institute Co's Operating Cash Flow per Share or its related term are showing as below:

XKRX:261780' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -12.4   Med: -4.55   Max: 3.3
Current: 3.3

During the past 5 years, CHA Vaccine Research Institute Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 3.30% per year. The lowest was -12.40% per year. And the median was -4.55% per year.

XKRX:261780's 3-Year OCF Growth Rate is ranked worse than
50.32% of 1240 companies
in the Biotechnology industry
Industry Median: 3.55 vs XKRX:261780: 3.30

CHA Vaccine Research Institute Co Operating Cash Flow per Share Historical Data

The historical data trend for CHA Vaccine Research Institute Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CHA Vaccine Research Institute Co Operating Cash Flow per Share Chart

CHA Vaccine Research Institute Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Operating Cash Flow per Share
-138.18 -220.52 -203.27 -196.25 -199.69

CHA Vaccine Research Institute Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -55.85 -64.60 -49.77 -65.99 -18.07

Competitive Comparison of CHA Vaccine Research Institute Co's Operating Cash Flow per Share

For the Biotechnology subindustry, CHA Vaccine Research Institute Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CHA Vaccine Research Institute Co's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CHA Vaccine Research Institute Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where CHA Vaccine Research Institute Co's Price-to-Operating-Cash-Flow falls into.



CHA Vaccine Research Institute Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

CHA Vaccine Research Institute Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )=Cash Flow from Operations (A: Dec. 2023 )/Shares Outstanding (Diluted Average) (A: Dec. 2023 )
=-5293.252/26.508
=-199.69

CHA Vaccine Research Institute Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )=Cash Flow from Operations (Q: Dec. 2023 )/Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
=-474.969/26.285
=-18.07

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-198.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CHA Vaccine Research Institute Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of CHA Vaccine Research Institute Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


CHA Vaccine Research Institute Co (XKRX:261780) Business Description

Traded in Other Exchanges
N/A
Address
560 Dunchon-daero, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR, 13230
CHA Vaccine Research Institute Co Ltd is a research-oriented biotechnology company. It researches and develops a broad range of vaccine products targeting infectious disease as well as chronic disease.

CHA Vaccine Research Institute Co (XKRX:261780) Headlines

No Headlines